Reliability of candida skin test in the evaluation of T-cell function in infancy by Reda, Shereen M. et al.
Egypt J Pediatr Allergy Immunol 2017;15(1):25-30. 
25 
 
Reliability of candida skin test in the evaluation of T-cell function in infancy 
 
INTRODUCTION 
The function of T cells is to recognize specific 
“non-self” antigens, during antigen presentation, 
leading to generation of specific responses that are 
tailored to maximally eliminate pathogens or 
pathogen-infected cells.1 Measurement of cell-
mediated immunity can be done both in vitro and in 
vivo. However, assays are plagued by 
standardization problems, biological variability, and 
technical difficulties. Most tests are expensive and 
highly specialized making referral to a clinical 
immunologist necessary.2  
Cutaneous delayed-type hypersensitivity (DTH) 
is the classic in vivo test of cellular immunity which 
measures the recall response to an intradermal 
injection of an antigen to which an individual has 
already been exposed over a period of time.3 A 
panel of four reagents can be used for DTH testing: 
Candida albicans extract, Tetanus toxoid, purified 
protein derivative (PPD), and Trichophyton.4 The 
incidence of DTH reactions to unstandardized 
Candida antigens has been reported to vary from 52 
- 89%, depending upon the strength of the antigen 
and the induration diameter required for a positive 
test.5 Infants are able to respond, but the test is not 
considered generally reliable under the age of 1 
year.6 
DTH testing is advantageous due to its ease and 
low cost; it is a useful screening test in many 
instances of suspected cellular immune deficiency. 
The skin response following intradermal 
inoculation of an antigen is dependent on the 
specific memory T cells and results in a local 
reaction after 48–72 hours due to recruitment of 
mononuclear cells and neutrophils. The presence of 
one or more positive DTH skin tests generally 
indicates an intact cell-mediated immunity. 
However, an impairment in any step of the response 
pathway can lead to a negative test result. In 
addition, the DTH response is often suppressed 
during viral and bacterial infections, and even with 
live attenuated vaccines administration including 
the combined measles, mumps, and rubella vaccine. 
DTH skin reactivity is also suppressed by anti-
inflammatory drugs such as glucocorticoids and 
other immunosuppressants such as cyclosporine, 
tacrolimus, and mycophenolic acid.7 
We sought to investigate the reliability of 
manually prepared candida skin test in the 
evaluation of T cell function in infants above one 
year of age and its correlation with the in-vitro 
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functional assessment of T cells. The ultimate 
objective is to validate the use of this simple 
inexpensive test as a screening tool for T cell 
function in infants. 
 
METHODS 
This cross-sectional study comprised 25 clinically 
healthy infants enrolled from the Outpatient Clinic 
of Children’s Hospital, Ain Shams University. 
Infants with severe lymphopenia (<1500/mm3), or 
with clinical signs of infection at the time of 
enrollment were excluded from the study. We also 
excluded infants with any chronic illness including 
malnutrition and those receiving corticosteroid or 
any immunosuppressive therapy or received recent 
live vaccines. 
The study protocol gained approval from the 
Local Ethics’ Committee of the Pediatric 
department, Ain Shams University and an informed 
written consent was obtained from parents or care 
givers of each infant before enrollment in the study.  
All recruited infants were subjected to full history 
taking with special emphasis on history of 
infections or chronic illness, vaccination history, or 
any complication following vaccination. Infants 
underwent evaluation for growth parameters and for 
exclusion of the presence of infection or underlying 
chronic illness. 
Study measurements 
1- Complete blood counting (CBC): EDTA 
(K3EDTA) vacutainer with concentration of 1.2 
mg of the anhydrous salt per ml of blood was 
used. The CBC was done using the automated 
cell counter coulter® LH 750 cell counter 
(Coulter Corporation, Florida, USA), with 
manual white cells differential count. 
2- Lymphocyte culture with PHA stimulation and 
measurement of IFN-γ by enzyme- linked 
immunosorbent assay (ELISA) in the 
supernatant of cultured mononuclear cells 
before and after PHA stimulation. Heparinized, 
preservative-free vacutainers were used. 
Samples were processed within two hours of 
collection as described below. 
• Reagents for in vitro stimulation of peripheral 
blood mononuclear cells (PBMCs): 
Sterile cell culture RPMI 1640w/ L-Glutamine and 
Amphotericin B antifungal were provided by Lonza 
(Walkersiville, USA). Penicillin / streptomycin and 
Gentamycin were obtained from Sigma (St. Louis, 
Mo.). Fetal bovine serum (FBS) and 
Phytohemagglutinin (PHA) were provided by 
Invitrogen, Ave Carlsbad, USA. Assay Max Human 
IFN-gamma ELISA Kit was obtained from 
ASSAYPRO, SACHIN 394230 Surat, INDIA for 
detection of IFN-γ in the culture supernatant. 
• Isolation of PBMCs and lymphoproliferation 
assay: 
PBMCs were separated from whole blood by 
Ficoll-Hypaque (Amersham Biosciences) density 
gradient centrifugation. Cells were treated with red 
blood cell lysing buffer (155 mM NH4Cl, 10 mM 
NaHCO3, and 0.1 mM EDT; pH 7.4) to lyse red 
blood cells. PBMCs freshly harvested from the 
studied infants were incubated in 96-well tissue 
culture plates (2 × 105 cells in 0.2 ml/well) in RPMI 
medium supplemented with 10% heat-inactivated 
fetal bovine serum, 100 units of penicillin G per ml, 
100 µg/ml of streptomycin and 0.25 µg/ml of 
amphotericin B. Cells were cultured with medium 
alone (without stimulation) and with stimulation by 
Phytohemagglutinin (PHA) (1ug/ml) and at 37°C 
with 5% CO2. The cultures were incubated for 5 
days.  
• IFN-γ detection by ELISA:  
At the end of the incubation period; cell-free 
supernatants were collected and frozen at -70o C 
until cytokine levels were determined by ELISA, 
using AssayMax Human IFN-γ IgG semi-
quantitative ELISA kit, (ASSAYPRO) 
(www.assaypro.com), USA, to assay the T 
lymphocyte function in response to the in-vitro 
stimulation. Polyclonal antibody specific for human 
IFN-γ has been pre-coated into a 96 –well 
microplate. IFN-γ in standards and samples is 
sandwiched by immobilized antibodies and 
biotinylated polyclonal antibody specific for IFN-γ, 
which is recognized by a streptavidin – peroxidase 
conjugate. All unbound material is then washed 
away and a peroxidase enzyme substrate is added. 
The color development is stopped and the intensity 
of color is measured at optical density (450nm) 
with reference filter 570 nm by using an ELISA 
reader then the concentrations of samples were 
determined from the standard curve. 
• As there are no well-defined age related 
reference ranges for serum gamma interferon 
level and as patients differs in their IFN-γ 
baseline levels as well as their levels after 
mitogen stimulation8, so the following values 
were calculated for IFN-γ results: 
Fold of increase = final value divided by the initial 
value 
Percentage of increase= (final value - the initial 
value) / initial value multiplied by 100.  
3- In-vivo T cell function test (Candida 
intradermal test):  
Candida intradermal test was done by intradermal 
injection of 0.1 ml of manually prepared Candida 
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Albicans extract (1:100) in the volar surface of the 
forearm after skin sterilization with alcohol. The 
test reagent was prepared in the Microbiology 
Department, Ain-Shams University. The test was 
read at 48 hours and 72 hours by palpating the 
indurated area and calculating the average of the 
longest and midpoint orthogonal diameters. A 
positive DTH reaction consists of induration ≥ 5 
mm, indicating an intact T cell function7.  
 
Statistical Analysis 
Data were analysed using an SPSS (version 20) 
statistical software package under Windows 7 
operating system for IBM compatible PC. 
Arithmetic mean and standard deviation was 
calculated for categorized parametric data. 
Comparison of different variables in various groups 
was done using student t and Mann-Whitney U 
tests. Wilcoxon signed ranks’ test was used to 
compare multiple readings of the same variable. 
Spearman’s correlation coefficient was used for 
relating non-parametric variables. A probability p 
value ≤ 0.05 for all tests was considered significant.  
 
RESULTS 
The age of enrolled infants ranged between 14 
and 24 months (mean±SD = 19.2±3.1 months). 
They were 17 boys (68%) and 8 girls (32%). The 
weight percentiles ranged from 2.9 to 97.3 (mean ± 
SD = 49.86±34.1) and the length percentiles ranged 
from 11.3 to 95.3 (mean±SD = 45.62± 22.57).   
Candida skin test was positive in 17 out of the 
25 infants (68%). Among the 8 infants with 
negative results, two developed induration 
diameters of 2 mm while 6 infants had no 
induration at all. Induration diameters ranged from 
0 to 20 mm (mean±SD = 9.84± 6.61mm). Analysis 
of results obtained after in-vitro PHA stimulation of 
cultured isolated mononuclear cells showed 
significant rise in the mean level of IFN-γ after 
PHA stimulation (mean±SD: 0.83±0.29 ng/ml) 
compared to basal levels (mean ± SD = 0.16 ± 0.16 
ng/ml) (z=-2.088, p=0.037) (Figure 1). The rates of 
increase ranged from 24% to 4450% (median 
(IQR): 564 (147-1650) %). The rise in IFN release 
after PHA stimulation mounted up to 1.45-38 folds. 
A significantly positive correlation was observed 
between Candida intradermal test induration 
diameters and the weight percentiles for age (r= 0.5, 
p= 0.01) (Figure 2). However, the Candida test 
induration diameter did not correlate significantly 
to IFN-γ expression before and after PHA 
stimulation (p values were 4.2 and 7.9 respectively) 
Clinical and laboratory data of the studied 
infants did not vary significantly with the Candida 
intradermal test results except for the weight 
percentiles that were significantly higher in the 
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r= 0.5, p= 0.01 
 
Figure 2. Positive correlation between candida test induration diameter and body weight percentile 
 
 
Table 1. Variation of clinical and laboratory data according to Candida skin test results 
 
Parameters 
Candida test positive  
(n=17)                           
Candida test negative                          
(n=8) 
Comparison 
 Range Mean± SD Range Mean± SD Z/t P 
Age (months) 14-24 19.41 3.2 16-24 19.88 3.4 t=0.33 0.75 
Weight percentiles 6.3-97.3 57.0 31.70 2.9-79.4 24.25 25.67 t=2.54 0.02 
Length percentiles 11.3-74.5 45.96 21.77 13.6-68.8 37.02 16.70 Z=1.02 0.31 
WBC (x103/mm3) 7-15 11.49 2.39 5.9-16 10.97 3.10 t=0.45 0.65 
ANC count (x103/mm3) 1.5-10.9 4.94 2.44 1.5-8.1 3.58 2.25 Z=1.54 0.12 
ALC count (x103/mm3) 3.2-9.9 5.47 1.69 3.4-7.8 6.23 1.53 t=1.08 0.29 
IFN γ basal (ng/ml) 0.01-0.42 0.162 0.141 0.03-0.65 0.152 0.207 Z=0.46 0.67 
IFN γ after stimulation (ng/ml) 0.38-1.00 0.914 0.193 0.08-1.00 0.789 0.393 Z=0.39 0.79 




Testing of DTH to recall antigens has been 
suggested as a more simple and less expensive 
method of measurement of T cell function, in 
comparison to the in-vitro proliferation assays, 
although being a less sensitive alternative.2 Both 
standardized and non-standardized candida 
preparations for intradermal skin tests are used in 
clinical practice with variable results ranging from 
23 % below the age of 1 year and up to 64 % above 
that age.6-8 Our results showed that 68% of infants 
who underwent candida intradermal skin testing 
had positive results (≥5 mm) which is higher than 
the figure reported by Ohri and colleagues.6 In their 
study, positive skin test response was elicited in 
64% of individuals who were subjected to a 
standardized Candida albicans skin test (Candin). In 
the same study, there was a 27% (3/11) positive 
Candin response for subjects below 1 year of age. 
The difference is possibly due to early exposure to 
Candida albicans in our series that belong to the 
low/middle socioeconomic sector of our 
community. For the purpose of assessing T-cell 
function diagnostically, the intradermal test may be 
performed with any antigen to which the patient has 
been exposed. Examples other than Candida include 
tetanus and diphtheria toxoids, streptococcus, 
Trichophyton, and Proteus. Glucocorticosteroids 
and other immunosuppressive drugs may blunt the 
response; the reaction may also be suppressed 
during acute infectious illnesses. In these situations, 
or when the interpretation of a negative result is 
unclear, an in vitro method of measuring T-cell 
function should be used.9, 10 
In the current study, all infants had significant 
response to PHA stimulation with increased IFN-γ 
production. Activation of T lymphocytes by 
antigens, alloantigens, and mitogens leads to the 
release of a number of lymphokines such as 
interleukin-2 (IL-2) and immune interferon (IFN-γ). 
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The production of IFN-γ following PHA 
stimulation varies significantly with age being 
lowest in cord blood lymphocytes and highest in 
adults. Therefore, values of such test especially in 
patients with suspected T cell immune defects 
should be assessed in comparison to normal age 
matched healthy controls.11 In in-vitro T cell 
proliferation assays, nonspecific mitogens like PHA 
and concanavalin A can rapidly stimulate the 
majority of T cells (80 to 100 %), and these assays 
can be performed in 3 days. On the other hand, the 
use of specific antigens for testing will require 
antigen processing and presentation to specific T 
cells. These latter tests require about 5 to 7 days in 
culture and peripheral blood mononuclear cells 
from a healthy control should be evaluated in 
parallel for comparison. However, these tests may 
not be able to detect defects of T-cell interaction 
with other cell types that will lead to only partial 
impairment of the test results in response to in-vitro 
stimulation. Similarly, partial impairment of T cell 
proliferation does not necessarily indicate that the 
cells are incapable of generating effector responses 
that are sufficient for protection against many 
pathogens.9,12 
In our series, except for weight centile, other 
clinical and laboratory parameters showed no 
variation according to the candida skin test results. 
Also, infants with positive skin test were 
comparable to those with negative results in terms 
of their IFN-γ levels before and after PHA 
stimulation. IFN-γ levels before and after PHA 
stimulation did not correlate with the candida test 
induration diameter. This may suggest that negative 
skin response to candida antigen in an otherwise 
healthy child should not be interpreted as 
immunodeficiency. A positive response to intra-
dermal candida antigen injection requires uptake 
and processing of antigen by antigen presenting 
cells, their interaction with CD4+ helper T cells, 
cytokine production by T cells, and subsequent 
recruitment and activation of monocytes and 
macrophages. Thus, skin testing may be a sensitive 
indicator of intact cellular immunity, but negative 
results must be interpreted with caution, because an 
impairment in any step of the response pathway 
will lead to a negative response. Repetition and 
further investigations should be conducted before 
interpretation.13 Elucidation of the value of candida 
intradermal test in screening for T-cell functions 
and judging its predictive values for intact cellular 
immunity in infants necessitates controlling the 
results by a group of age matched patients with 
significant T-cell defects. A study by Hossny et al,14 
concluded that a negative Candida skin test is more 
likely to be found (75 %) among patients with 
laboratory evidence of T-cell immunodeficiency in 
comparison to those without (18 %). However, the 
age categories in their series were higher than ours. 
 
CONCLUSION 
Candida intradermal skin testing could serve as an 
easy cost-effective test for evaluation of T cell 
function. Our results revealed a sensitivity of 68 % 
in healthy infants above the age of one year. The 
small sample size and lack of age related reference 
ranges for gamma interferon production by PHA 
stimulated cultured mononuclear cells were the 
main limiting factors in our study. 
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